NSE · SENORES
Senores Pharmaceuticals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#752
of 5,004 stocks
▼ 61W
Peak #746 · 21 Sep 2026
Senores Pharmaceuticals Limited is a midcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and earns a healthy return on equity.
Market Cap
6,381.61 Cr
P/E Ratio
52.51
P/B Ratio
6.62
ROE
12.60%
ROCE
15.61%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 180.21 Cr | 175.19 Cr | 174.56 Cr | 161.76 Cr |
| Net Profit | 30.45 Cr | 36.67 Cr | 33.58 Cr | 30.12 Cr |
| EPS | 6.61 | 7.96 | 7.29 | 6.54 |
| Operating Profit | 46.63 Cr | 55.86 Cr | 49.93 Cr | 46.83 Cr |
Shareholding pattern
Promoter
45.82%
Public
54.18%
PUBLIC BREAKDOWN
FII
6.62%
DII
9.77%
MF (within DII)
6.56%
Individuals
30.12%
Mutual fund holdings
₹366.62
Cr total
14
Schemes
6
Fund Houses
₹366.62 Cr
Total Exposure
HSBC Mutual Fund₹190.98 Cr (52.1%)
Bajaj Finserv Mutual Fund₹90.37 Cr (24.7%)
Mahindra Manulife Mutual Fund₹74.45 Cr (20.3%)
WhiteOak Capital Mutual Fund₹7.69 Cr (2.1%)
TRUST Mutual Fund₹3.03 Cr (0.8%)
Others₹0.10 Cr (0.0%)
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.